Advertisement
Canada markets closed
  • S&P/TSX

    21,823.22
    +94.67 (+0.44%)
     
  • S&P 500

    5,064.20
    +45.81 (+0.91%)
     
  • DOW

    38,225.66
    +322.37 (+0.85%)
     
  • CAD/USD

    0.7322
    +0.0008 (+0.11%)
     
  • CRUDE OIL

    79.09
    +0.14 (+0.18%)
     
  • Bitcoin CAD

    81,076.82
    +2,814.72 (+3.60%)
     
  • CMC Crypto 200

    1,281.74
    +11.00 (+0.87%)
     
  • GOLD FUTURES

    2,312.10
    +2.50 (+0.11%)
     
  • RUSSELL 2000

    2,016.11
    +35.88 (+1.81%)
     
  • 10-Yr Bond

    4.5710
    -0.0240 (-0.52%)
     
  • NASDAQ futures

    17,774.75
    +125.00 (+0.71%)
     
  • VOLATILITY

    14.68
    -0.71 (-4.61%)
     
  • FTSE

    8,172.15
    +50.91 (+0.63%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6816
    -0.0001 (-0.01%)
     

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

The Bad News Heading Into AbbVie's First-Quarter Earnings Report

AbbVie stock has slumped 9% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.